PGIM Securitized Income ETF
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PINC research report →
Price Chart
About the company
Seeks to maximize total return, through a combination of current income and capital appreciation.
- CEO
- Stuart S. Parker
- IPO
- 2026
- HQ
- Newark, NJ, US
Get TickerSpark's AI analysis on PINC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $24.60M
- P/E
- 59.28
- Fwd P/E
- 27.82
- PEG
- -0.55
- P/S
- 0.03
- P/B
- 2.70
- EV/EBITDA
- 1.51
- Div Yield
- 2.12%
- Gross Margin
- 73.01%
- Op Margin
- 12.11%
- Net Margin
- 9.40%
- ROE
- 4.70%
- ROIC
- 2.65%
- 52W High
- $50.29
- 52W Low
- $49.04
- 50D MA
- $49.25
- 200D MA
- $49.68
- Beta
- 0.34
- RSI (14)
- 47
- Avg Volume
- 1.26K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Premier finished fiscal 2025 ahead of expectations, with stronger-than-expected Supply Chain Services offsetting a still-rebuilding advisory business and setting up a transition year in fiscal 2026.· August 19, 2025
- Full-year net revenue of $986 million beat the midpoint of guidance by $11 million, and adjusted EPS of $1.54 beat the high end of guidance by $0.11.
- Q4 net revenue was $258 million; adjusted EBITDA was $71 million with a 27.6% margin, and adjusted EPS was $0.46.
- Supply Chain Services outperformed on better contract penetration and new-member spend, while gross administrative fees grew over 3% in fiscal 2025.
- Management signed 4 large advisory deals and expects Performance Services to return to double-digit growth in fiscal 2026, with advisory growth above 25%.
- Fiscal 2026 guidance calls for stabilization, with total net revenue of $940 million to $1 billion, adjusted EBITDA of $230 million to $245 million, and adjusted EPS of $1.33 to $1.43.
Premier said full-year fiscal 2025 net revenue was $986 million, $11 million above the midpoint of guidance, and adjusted EPS was $1.54, $0.11 above the high end of guidance. Q4 net revenue was $258 million, down from the prior-year period but up 1% sequentially; GAAP net income from continuing operations was $18 million and EPS was $0.22. Q4 adjusted EBITDA was $71 million, flat sequentially, with a 27.6% margin, and adjusted EPS was $0.46. For fiscal 2026, management guided to total net revenue of $940 million to $1 billion, Supply Chain Services revenue of $590 million to $620 million, Performance Services revenue of $350 million to $380 million, adjusted EBITDA of $230 million to $245 million, and adjusted EPS of $1.33 to $1.43. Q1 fiscal 2026 guidance was net revenue of $230 million to $245 million, adjusted EBITDA of $45 million to $50 million, and adjusted EPS of $0.27 to $0.32.
Mike Alkire said the company finished the year strongly because Supply Chain Services beat expectations and advisory momentum improved meaningfully. He emphasized that member hospitals are under mounting financial pressure from reimbursement cuts, labor issues, and tariff uncertainty, which he believes increases demand for Premier’s value-based support. He also highlighted the IllumiCare acquisition as a strategic AI-enabled expansion that strengthens clinical decision support and broadens the addressable market.
Glenn Coleman said fiscal 2025 full-year revenue, adjusted EBITDA, and adjusted EPS all exceeded expectations, with net revenue of $986 million and adjusted EPS of $1.54. He noted Q4 adjusted EBITDA of $71 million and adjusted EPS of $0.46 were helped by stronger Supply Chain Services flow-through and a lower share count. Free cash flow was $181 million in fiscal 2025, with 69% conversion; management expects 70% to 80% conversion in fiscal 2026 and a cash tax rate below 5% over the next 5 years. He also said cash and cash equivalents were $84 million at June 30, debt on the credit facility was $280 million, and the company completed a $200 million accelerated share repurchase, bringing total repurchases to $800 million under the expired $1 billion authorization.
Analysts focused on tariff-related buying behavior, the strength and durability of the advisory rebound, the cadence of contract fee-share resets, and the economics of IllumiCare and Contigo. Management said it did not see significant pull-forward buying due to tariffs, and that any impact remains de minimis so far because contracts are firm and the process is member-led. On advisory, management said the recent wins were driven by both market demand and Premier’s stronger team and technology, with large contracts, milestones, and headcount ramp meaning revenue recognition will be back-end loaded in fiscal 2026. On IllumiCare, management sized it at about $8 million to $10 million of revenue in fiscal 2026 with breakeven bottom-line impact, while Contigo is expected to contribute about $9 million of revenue and a $6 million EBITDA loss.
The call pointed to clear momentum in Supply Chain Services, with gross administrative fees up over 3% in fiscal 2025 and growth across MedSurg, pharmacy, food, and purchase services. Management also sounded increasingly confident that advisory is turning into a meaningful growth engine, citing 4 large wins, a robust pipeline, and expected growth above 25% in fiscal 2026. IllumiCare was framed as a high-return, strategically important addition that should enhance clinical decision support and drive growth beyond 2026.
Fiscal 2026 is explicitly a transition year, with lower revenue and profitability expected in the first half due to advisory headcount ramp and ongoing fee-share resets in Supply Chain Services. Management also said Supply Chain Services EBITDA margins should decline in 2026 because the fee-share adjustments are not yet complete, and enterprise license revenue is expected to be down due to fewer renewals. The company still sees some pressure from Contigo wind-down costs and ongoing uncertainty around reimbursement, Medicaid, and tariffs, even if those risks have not yet caused major disruptions.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- —
- Shares Outstanding
- 500.00K
- Float Shares
- —
of shares held by institutions
277 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Nuveen Asset Management, LLC | 185.40K | ▼ 21.08K |
| Point72 Asia (Singapore) Pte. Ltd. | 98.65K | ▲ 98.65K |
| Congress Wealth Management LLC / De / | 48.90K | ▲ 22.73K |
| Ccm Investment Group, LLC | 36.54K | ▲ 1.71K |
| Burren Capital Advisors Ltd | 34.95K | ▲ 34.95K |
| Caxton Associates LP | 32.27K | ▼ 36.91K |
| Cubist Systematic Strategies, LLC | 13.04K | ▲ 13.04K |
| Point72 (Difc) Ltd | 9.16K | ▲ 9.16K |
| Point72 Europe (London) Llp | 5.47K | ▲ 5.47K |
| Lindbrook Capital, LLC | 4.38K | ▲ 3.32K |
| First Horizon Advisors, Inc. | 1.13K | ▲ 751 |
| Shell Asset Management Co | 1.12K | ▼ 2.12K |
Held by 20 ETFs
Biggest fund positions in PINC by dollar value.
Our PINC coverage
Recent articles, reports, and earnings notes.
No research on PINC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PINC report →BellRing Brands Q4 Earnings Beat Estimates on Strong Premier Volumes
zacks.com · Nov 19
BellRing Jumps 24% On Uncut Guidance, But Premier Still Has To Sell
seekingalpha.com · Nov 19
Month-end portfolio data now available for Federated Hermes Premier Municipal Income Fund
prnewswire.com · Nov 16
Premier Development & Investment, Inc. Commits to Promised Investor Relations Engagements
globenewswire.com · Nov 16
Premier Foods plc (PRRFY) Q2 2027 Earnings Call Transcript
seekingalpha.com · Nov 12
Bank of America Brings the Erewhon Membership to BofA Rewards
prnewswire.com · Nov 10
Federated Hermes Premier Municipal Income Fund declares dividend
prnewswire.com · Nov 10
Premier American Uranium Completes US$5 Million Strategic Equity Investment by DISA Uranium; IsoEnergy Increases its Strategic Holding
globenewswire.com · Nov 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.